These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1703281)

  • 1. Inosine pranobex for preventing AIDS in patients with HIV infection.
    Forthal DN
    N Engl J Med; 1991 Feb; 324(7):491-2. PubMed ID: 1703281
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
    Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
    N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inosine pranobex--is a single positive trial enough?
    Kweder SL; Schnur RA; Cooper EC
    N Engl J Med; 1990 Jun; 322(25):1807-9. PubMed ID: 1693175
    [No Abstract]   [Full Text] [Related]  

  • 4. ACTH--inosine pranobex in the treatment of AIDS. Encouraging results.
    Addo E; McFarlane H; Parsad K
    West Indian Med J; 1989 Sep; 38(3):142-7. PubMed ID: 2482585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A warning against exaggerated optimism about isoprinosine in HIV infection].
    Norrby R
    Lakartidningen; 1990 Aug; 87(32-33):2487-8. PubMed ID: 1697923
    [No Abstract]   [Full Text] [Related]  

  • 6. [Promising results of a Danish-Swedish clinical trial: isoprinosine administered to HIV positive patients prevented development of AIDS].
    Lennholm B
    Lakartidningen; 1990 Jun; 87(26-27):2253. PubMed ID: 1694549
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunomodulating treatment of patients with HIV infection].
    Skotnicki AB; Kornaszewski W
    Przegl Dermatol; 1989; 76(4):285-91. PubMed ID: 2483589
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of zidovudine and concomitant inosine-pranobex in AIDS patients.
    De Simone C; Ferrazzi M; Bitonti F; Falciano M; Tzantzoglou S; Delia S; Sorice F
    Immunopharmacol Immunotoxicol; 1988; 10(4):437-41. PubMed ID: 2469710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS therapy.
    Stephens EJ
    N Z Med J; 1986 Feb; 99(795):72-3. PubMed ID: 2418393
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunostimulation in the lymphadenopathy syndrome and in AIDS--Inosiplex (inosin pranobex, methisoprinol].
    Grossmann D; Behrens MI
    Onkologie; 1987 Jun; 10(3 Suppl):12-6. PubMed ID: 2443884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance.
    Glasky AJ; Gordon JF
    Cancer Detect Prev Suppl; 1987; 1():597-609. PubMed ID: 2446760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inosine pranobex in the treatment of HIV infection: a review.
    De Simone C; Famularo G; Tzantzoglou S; Moretti S; Jirillo E
    Int J Immunopharmacol; 1991; 13 Suppl 1():19-27. PubMed ID: 1726683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inosine pranobex and zidovudine metabolism.
    De Simone C; Tzantzoglou S; Vullo V; Catania S; Trinchieri V
    Lancet; 1989 Oct; 2(8669):977. PubMed ID: 2477658
    [No Abstract]   [Full Text] [Related]  

  • 14. Inosine pranobex in the combination therapy of HIV infection.
    De Simone C; Famularo G; Giacomelli R; Tzantzoglou S
    Pharmacol Res; 1992 Sep; 26 Suppl 2():60-1. PubMed ID: 1384023
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controlled, clinical trial of isoprinosine administration to HIV-infected patients. Results of a Danish/Swedish multicenter study. The Scandinavian Isoprinosine Study Group].
    Thorsen S; Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO
    Ugeskr Laeger; 1994 May; 156(22):3314-8. PubMed ID: 7520643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical. A new approach to combat viruses.
    Hopkins S
    Nurs Mirror; 1985 May; 160(18):28-9. PubMed ID: 2581230
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune dysfunctions and therapeutic interventions in patients with acquired immune deficiency syndrome and AIDS-related complex.
    Tsang PH; Wallace JI; Roboz JP; Sei Y; Bekesi JG
    Mt Sinai J Med; 1987 Feb; 54(2):121-8. PubMed ID: 2437445
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogen for herpes, AIDS?
    Wenz C
    Nature; 1984 Oct 4-10; 311(5985):404. PubMed ID: 6207432
    [No Abstract]   [Full Text] [Related]  

  • 19. Knowledge and attitude regarding human immunodeficiency virus/acquired immunodeficiency syndrome in dermatological outpatients.
    Kouznetsov L; Kuznetsov AV; Ruzicka T; Matterne U; Wienecke R; Zippel SA
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):927-33. PubMed ID: 19486230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inosiplex treatment of acquired immunodeficiencies: a clinical model for effective immunomodulation.
    Glasky AJ; Gordon J
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):35-40. PubMed ID: 2422507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.